These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26642869)

  • 1. Flagging Drugs That Inhibit the Bile Salt Export Pump.
    Montanari F; Pinto M; Khunweeraphong N; Wlcek K; Sohail MI; Noeske T; Boyer S; Chiba P; Stieger B; Kuchler K; Ecker GF
    Mol Pharm; 2016 Jan; 13(1):163-71. PubMed ID: 26642869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP.
    Jain S; Grandits M; Richter L; Ecker GF
    J Comput Aided Mol Des; 2017 Jun; 31(6):507-521. PubMed ID: 28527154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
    Cheng Y; Woolf TF; Gan J; He K
    Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.
    Ritschel T; Hermans SM; Schreurs M; van den Heuvel JJ; Koenderink JB; Greupink R; Russel FG
    Chem Res Toxicol; 2014 May; 27(5):873-81. PubMed ID: 24713091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
    Stieger B
    Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Kruglov EA; Gautam S; Guerra MT; Nathanson MH
    Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
    Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
    Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
    Byrne JA; Strautnieks SS; Mieli-Vergani G; Higgins CF; Linton KJ; Thompson RJ
    Gastroenterology; 2002 Nov; 123(5):1649-58. PubMed ID: 12404239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
    Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile salt export pump (BSEP/ABCB11): trafficking and sorting disturbances.
    Hayashi H; Sugiyama Y
    Curr Mol Pharmacol; 2013 Jul; 6(2):95-103. PubMed ID: 23876151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
    Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
    Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
    Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
    Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.